Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM® (obiltoxaximab), for strategic government partners.
Company Details
- Employees
- 29
- Founded
- -
- Address
- 2001 Route 46, Suite 310, Parsippany,new Jersey 07054,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://elusys.com/
- Keywords
- Biodefense, Anthrax, ANTHIM, NYXTHRACIS, Obiltoxaximab.
- HQ
- Parsippany, New Jersey
Elusys Therapeutics, Inc. Questions
Elusys Therapeutics, Inc.'s website is https://elusys.com/
Elusys Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/elusys-therapeutics-inc
Elusys Therapeutics, Inc. has
29 employees.
View email and phone details for 29
employees at Elusys Therapeutics, Inc..
Elusys Therapeutics, Inc.'s industry is
Biotechnology Research
Elusys Therapeutics, Inc.'s top competitors are
Nextcure, Inc.,
Melinta Therapeutics,
Emergent Biosolutions,
Tactical Edge Systems,
Scorpius Biomanufacturing, Inc.,
Scpx Holdings,
Engineering Biology Research Consortium,
Lisata Therapeutics, Inc.,
Built Robotics,
Capstan Therapeutics.
Elusys Therapeutics, Inc.'s categories are Biotechnology Research
Elusys Therapeutics, Inc.'s founding year is 1998
